Literature DB >> 32965080

Further delineation of HIDEA syndrome.

Sateesh Maddirevula1, Tawfeg Ben-Omran2, Mariam AlMureikhi2, Wafa Eyaid3,4, Hisham Arabi3,4, Hisham Alkuraya5, Abdullah Alfaifi6, Abdullah Hamed Alfalah7, Hessa S Alsaif1, Firdous Abdulwahab1, Majid Alfadhel3,4, Fowzan S Alkuraya1,8.   

Abstract

Recently, the genetic cause of HIDEA syndrome (hypotonia, hypoventilation, intellectual disability, dysautonomia, epilepsy, and eye abnormalities) was identified as biallelic pathogenic variants in P4HTM, which encodes an atypical member of the prolyl 4-hydroxylases (P4Hs) family of enzymes. We report seven patients from four new families in whom HIDEA was only diagnosed after whole-exome sequencing (WES) revealed novel disease-causing variants in P4HTM. We note the variable phenotypic expressivity of the syndrome except for cognitive impairment/developmental delay, and hypotonia, which seem to be consistent findings. One patient only presented with hypotonia, developmental delay, and abnormal eye movements, which highlights the challenge in diagnosing milder cases with this new syndrome. Other notable features include mild facial dysmorphism, obesity, and brain dysmyelination and atrophy. We conclude that HIDEA is a highly variable syndrome and suspect that a large fraction of patients will be diagnosed via reverse phenotyping after recessive P4HTM variants are identified by agnostic genomic sequencing assays.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  HIDEA syndrome; P4HTM; developmental delay; hypoventilation; intellectual disability; reverse phenotyping

Mesh:

Substances:

Year:  2020        PMID: 32965080     DOI: 10.1002/ajmg.a.61885

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  1 in total

1.  Biallelic P4HTM variants associated with HIDEA syndrome and mitochondrial respiratory chain complex I deficiency.

Authors:  Eleanor Hay; Louise C Wilson; Bethan Hoskins; Martin Samuels; Pinki Munot; Shamima Rahman
Journal:  Eur J Hum Genet       Date:  2021-07-20       Impact factor: 4.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.